Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Krystal Biotech Inc
F:4KB
Krystal Biotech Inc
F:4KB
Price:
292.4
EUR
-2.11%
Market Closed
Market Cap:
€8.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Krystal Biotech Inc
F:4KB
|
US |
|
B
|
Burlington Stores Inc
F:BUI
|
US |
|
F
|
Fortescue Metals Group Ltd
F:FVJ
|
AU |
Wall St Price Targets
4KB Price Forecast
Based on 14 analysts
Based on 14 analysts
-38% Downside
from
€292.4
today
Krystal Biotech Inc (4KB)’s 12-month stock price forecast through September 2027 has a consensus target of €181.43, implying 38% downside. The forecast is based on price targets from 14 Wall Street analysts.
4KB Analyst Rating
No ratings yet
No ratings yet
Krystal Biotech Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4KB's stock price target?
Price Target
181.43
EUR
181.43
EUR
According to Wall Street analysts, the average 1-year price target for 4KB is 181.43 EUR with a low forecast of 100.06 EUR and a high forecast of 229.34 EUR.
What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
22%
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
What is the Gross Profit forecast for Krystal Biotech Inc?
Projected CAGR
22%
22%
The compound annual growth rate for Gross Profit over the next 8 years is 22%.
What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
31%
31%
The compound annual growth rate for Operating Income over the next 8 years is 31%.
What is the Pre-Tax Income forecast for Krystal Biotech Inc?
Projected CAGR
50%
50%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 50%.
What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
21%
21%
The compound annual growth rate for Net Income over the next 8 years is 21%.